Anatara Lifesciences Ltd · ASX:ANR
Anatara Lifesciences — Shareholder Meeting (November 2022)
6 slides from Anatara Lifesciences's shareholder meeting presentation, Nov 11, 2022
Slide 1: GaRP Trial Update
For personal use only GaRP Trial Update: Kylie Wilkie, Clinical Trials Manager Confidential: for Internal use only. Not for distribution
Slide 2: GaRP trial - Summary
Garp trial- Summary For personal use only • On track for recruitment of Stage 1 participants (n=90) by end of 1Q23 • No Significant Adverse Events • Strong interest in the trial and support from gastroenterologists. • Trial protocol changes to enhance participation have been approved by Bellberry HR
Slide 3: Dose Determination and Efficacy Evaluation of the GaRP Dietary Supplement in IBS patients
Dose Determination and Efficacy Evaluation of the For personal use only Gastrointestinal ReProgramming (GaRP) Dietary supplement in IBS patients • A Randomized, Double-blind, Placebo-controlled clinical trial enrolling 200 IBS participants • Stage 1 (n=90, 1Q23) • To determine the safety and efficac
Slide 4: Current Study Flow
Current Study Flow For personal use only Eligibility 1 Landing page • Pre Screening questionnaires Download Claimit app eIC signed Screening period Active trial (8 weeks) Follow up period •IBS-SSS - weekly (2 weeks) Eligibility 2 •Rome IV Baseline period •IBS-AR – Weekly •Alarm symptoms (2 weeks) •S
Slide 5: Updated Study flow
Updated Study flow Eligibility 1 Eligibility 2 For personal use only Landing page • Pre Screening questionnaires Pre screening with nurse • Rome IV • Med HX • IBS-SS • Medications • Dietary history Baseline period Active trial (8 weeks) Follow up period eConsent (up to 2 weeks) •IBS-SSS - weekly (2
Slide 6: GaRP trial - Summary
Garp trial- Summary For personal use only • On track for Recruitment of Stage 1 participants (n=90) by end of 1Q23 • No Significant Adverse Events • Strong interest in the trial and support from gastroenterologists. • Protocol changes to enhance participation have been approved by Bellberry HREC, cu
Anatara Lifesciences — Shareholder Meeting (November 2022) on 6ix